Bioavailability/Bioequivalence on Biopharmaceutical Products
The Bioavailability Bioequivalence Research Center aims to become a regional center of excellence for assuring the safety and efficacy of generic pharmaceutical products for human use. It plays a key role in the drug development period for both new drug products and their generic equivalents. These studies are also important in the post approval period in the presence of certain manufacturing changes. Information in the overall set of data that ensure the availability of safe and effective medicines to patients and practitioners can be discussed
- Factors affecting bae
- BABE studies
- Assesssment of bioeqivalence
- In vivo/In vitro studies
- Latest Updates In BA/BE
Related Conference of Bioavailability/Bioequivalence on Biopharmaceutical Products
June 06-07, 2018
International Conference & B2B on Pharma Research and Development
Philadelphia, Pennsylvania, USA
June 08-09, 2018
8th International Conference and Exhibition on Pharma Audit, GMP, GCP & Quality Control
Philadelphia, Pennsylvania, USA
June 08-09, 2018
8th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR
Philadelphia, Pennsylvania, USA
June 27-28, 2018
4th International Conference on Drug Discovery, Designing and Development
Vancouver, British Columbia, Canada
August 29-30, 2018
International Conference And Exhibition on Drug Safety & Pharmacovigilance
Toronto, Canada
November 15-16, 2018
14th International Conference on Generic Drugs and Biosimilars
Frankfurt, Germany
Bioavailability/Bioequivalence on Biopharmaceutical Products Conference Speakers
Recommended Sessions
- Bioavailability/Bioequivalence on Biopharmaceutical Products
- Biologics and Biosimilars
- Biopharmaceutical Companies & Market Analysis
- Biopharmaceutical Pharmacovigilance
- Biopharmaceuticals
- Biopharmaceutics: Drug Discovery and Development
- Biotechnological Products
- Cellular and Gene Therapy
- clinical Trials on Biopharmaceutical Products
- Drug Delivery System of Biopharmaceutical Products
- Drug Disposition & Pharmacokinetics
- Drug Dissolution of Biopharmaceutical Products
- Entrepreneurs Investment Meet
- Pharmaceutical Regulatory Affairs And IPR
- Pharmacovigilance
- Therapeutic Biological Products
Related Journals
Are you interested in
- Adverse Drug Reactions - Drug Safety 2018 (Canada)
- Analytical method Quality Auditing - GMP and Pharma Audit 2018 (USA)
- Analytical strategies for pharmaceutical products - Pharma Research 2018 (USA)
- Anesthesia in Pain Treatment - Pain Medicine 2018 (USA)
- API: Active Pharmaceutical Ingredients - Pharma Research 2018 (USA)
- Array of clinical trials in biosimilars - Generic Biosimilars 2018 (Germany)
- Auditing Deviations, Product Complaints, and CAPA Systems - GMP and Pharma Audit 2018 (USA)
- BCS & IVIVC Based Biowaivers - Asian Biosimilars 2018 (Japan)
- Best Industry Practices - Regulatory Affairs 2018 (USA)
- Bio-Pharmaceutics - Pharma Congress 2018 (Poland)
- Bioavailability/Bioequivalence on Biopharmaceutical Products - Euro Biopharma 2018 (Netherlands)
- Bioequivalence Assessment - Asian Biosimilars 2018 (Japan)
- Bioinformatics in Clinical Research - Clinical Trials Congress 2018 (Singapore)
- Biologics & Biosimilars - Pharma Congress 2018 (Poland)
- Biologics and Biosimilars - Regulatory Affairs 2018 (USA)
- Biologics and Biosimilars - Euro Biopharma 2018 (Netherlands)
- Biopharmaceutical Companies & Market Analysis - Euro Biopharma 2018 (Netherlands)
- Biopharmaceutical Pharmacovigilance - Euro Biopharma 2018 (Netherlands)
- Biopharmaceutical Sciences - Drug Safety 2018 (Canada)
- Biopharmaceuticals - Euro Biopharma 2018 (Netherlands)
- Biopharmaceutics: Drug Discovery and Development - Euro Biopharma 2018 (Netherlands)
- Biosimilar and biologics - Generic Biosimilars 2018 (Germany)
- Biosimilar Companies and Market Analysis - Asian Biosimilars 2018 (Japan)
- Biosimilar development challenges - Generic Biosimilars 2018 (Germany)
- Biosimilar Market and Cost Analysis - Asian Biosimilars 2018 (Japan)
- Biosimilars Analytical Strategies - Asian Biosimilars 2018 (Japan)
- Biosimilars differentiated through novel drug delivery technologies - Generic Biosimilars 2018 (Germany)
- Biosimilars Research Pipeline - Asian Biosimilars 2018 (Japan)
- Biosimilars uptake and patient safety - Generic Biosimilars 2018 (Germany)
- Biotechnological Products - Euro Biopharma 2018 (Netherlands)
- Brexit Effect on Biosimilars - Asian Biosimilars 2018 (Japan)
- Cardiovascular Drug Discovery - Drug Designing 2018 (Canada)
- Case study mitigating risk in biosimilar development - Generic Biosimilars 2018 (Germany)
- Cellular and Gene Therapy - Euro Biopharma 2018 (Netherlands)
- Challenges in Developing Biosimilars - Asian Biosimilars 2018 (Japan)
- Chronicles of biosimilar production facility - Generic Biosimilars 2018 (Germany)
- Clinical Affairs and Regulatory Strategies - Regulatory Affairs 2018 (USA)
- Clinical and Bioanalytical laboratory Audits - GMP and Pharma Audit 2018 (USA)
- Clinical and Hospital Pharmacy - Pharma Congress 2018 (Poland)
- Clinical and Medical Case Reports - Clinical Trials Congress 2018 (Singapore)
- Clinical Audit in Pharmaceutical Development - GMP and Pharma Audit 2018 (USA)
- Clinical Data Management - Clinical Trials Congress 2018 (Singapore)
- Clinical Data Management and Analytics - Drug Safety 2018 (Canada)
- Clinical Database Management - Drug Safety 2018 (Canada)
- Clinical Research and Statistics - Drug Safety 2018 (Canada)
- Clinical Research On Different Diseases - Clinical Trials Congress 2018 (Singapore)
- Clinical Studies on Biosimilars - Asian Biosimilars 2018 (Japan)
- Clinical Trial Protocols - Drug Safety 2018 (Canada)
- Clinical Trial Site Management - Clinical Trials Congress 2018 (Singapore)
- Clinical Trial Site Selection and Management - Drug Safety 2018 (Canada)
- Clinical Trials and Clinical Research - Pharma Congress 2018 (Poland)
- Clinical Trials and Clinical Research Conducts - Clinical Trials Congress 2018 (Singapore)
- Clinical trials and Pharmacovigilance - Pharma Research 2018 (USA)
- Clinical Trials and Regulatory Affairs - Drug Designing 2018 (Canada)
- clinical Trials on Biopharmaceutical Products - Euro Biopharma 2018 (Netherlands)
- Computational Molecular Biology - Drug Designing 2018 (Canada)
- Computer Aided Drug Design (CADD) - Drug Designing 2018 (Canada)
- Contract & Sterile/Aseptic Manufacturing - GMP and Pharma Audit 2018 (USA)
- CRO (Contract Research Organization) Clinical Trials - Clinical Trials Congress 2018 (Singapore)
- Current GMP Guidelines (cGMP) & GxP in Pharmaceuticals - GMP and Pharma Audit 2018 (USA)
- Current GMP Guidelines (cGMP) & GxP in Pharmaceuticals: - Regulatory Affairs 2018 (USA)
- Current Regulations and Quality Standards - GMP and Pharma Audit 2018 (USA)
- Developing biosimilars and biobetters - Generic Biosimilars 2018 (Germany)
- Diversity in Industrial Clinical Trials and Clinical Research - Drug Safety 2018 (Canada)
- Drug Delivery and Targeting - Drug Designing 2018 (Canada)
- Drug Delivery System of Biopharmaceutical Products - Euro Biopharma 2018 (Netherlands)
- Drug Designing and Molecular Modelling - Drug Designing 2018 (Canada)
- Drug Discovery and Development - Clinical Trials Congress 2018 (Singapore)
- Drug Discovery and Development - Drug Designing 2018 (Canada)
- Drug discovery and NCEs - Pharma Research 2018 (USA)
- Drug Discovery in Preclinical Research - Drug Designing 2018 (Canada)
- Drug Disposition & Pharmacokinetics - Euro Biopharma 2018 (Netherlands)
- Drug Dissolution of Biopharmaceutical Products - Euro Biopharma 2018 (Netherlands)
- Drug Safety - Drug Safety 2018 (Canada)
- Drug Targeting and Design - Pharma Congress 2018 (Poland)
- Drugs Regulations - Drug Safety 2018 (Canada)
- Emerging Biosimilars in Therapeutics - Asian Biosimilars 2018 (Japan)
- Emerging Trends in Biosimilars - Asian Biosimilars 2018 (Japan)
- Entrepreneurs Investment Meet - Asian Biosimilars 2018 (Japan)
- Entrepreneurs Investment Meet - Euro Biopharma 2018 (Netherlands)
- Entrepreneurs Investment Meet - Clinical Trials Congress 2018 (Singapore)
- Entrepreneurs investment meet - Generic Biosimilars 2018 (Germany)
- Ethics in Clinical Trials and Research - Clinical Trials Congress 2018 (Singapore)
- Excipient Qualification and Supply Chain Controls - GMP and Pharma Audit 2018 (USA)
- Formulation Development - GMP and Pharma Audit 2018 (USA)
- Formulations and NDDS - Pharma Research 2018 (USA)
- Generic drugs, generic pills and generic medication - Generic Biosimilars 2018 (Germany)
- Generics and biosimilars industry strategy - Generic Biosimilars 2018 (Germany)
- Global generic trends and global pharma market - Generic Biosimilars 2018 (Germany)
- Global Regulatory Intelligence - Regulatory Affairs 2018 (USA)
- Globalization of Biosimilars - Asian Biosimilars 2018 (Japan)
- Globalization of Clinical Trials and Clinical Research - Clinical Trials Congress 2018 (Singapore)
- GMP in Food Industry - Regulatory Affairs 2018 (USA)
- GMP in Food Industry - GMP and Pharma Audit 2018 (USA)
- GMP in Microbiology and Biotechnology - GMP and Pharma Audit 2018 (USA)
- GMP, GCP and quality control - Generic Biosimilars 2018 (Germany)
- Goals and Strategies to Meet Audit Requirements - GMP and Pharma Audit 2018 (USA)
- Good Clinical Practices & Good Laboratory Practices - Regulatory Affairs 2018 (USA)
- Good Clinical Practices & Good Laboratory Practices - GMP and Pharma Audit 2018 (USA)
- Good Manufacturing Practices: The Gap within - GMP and Pharma Audit 2018 (USA)
- Good Pharmacovigilance Practice - Drug Safety 2018 (Canada)
- Hospital and Indutrial Pharmacy - Drug Safety 2018 (Canada)
- Impact of Brexit on Regulatory Framework - Regulatory Affairs 2018 (USA)
- Importance of Audit in Pharmaceutical Industry - GMP and Pharma Audit 2018 (USA)
- In Silico Clinical Trials - Clinical Trials Congress 2018 (Singapore)
- Industrial and Physical Pharmacy - Pharma Congress 2018 (Poland)
- Innovation and technology for biosimilar development - Generic Biosimilars 2018 (Germany)
- Innovations in Clinical Trials and Research - Clinical Trials Congress 2018 (Singapore)
- Intellectual Property Rights - Regulatory Affairs 2018 (USA)
- Intellectual Property Rights - Asian Biosimilars 2018 (Japan)
- Latest Biosimilars in Asian Scenario - Asian Biosimilars 2018 (Japan)
- Legal Issues and BPCI Act - Asian Biosimilars 2018 (Japan)
- Licensing, manufacturing and health economics - Generic Biosimilars 2018 (Germany)
- Marketing Authorizations - Regulatory Affairs 2018 (USA)
- Medical and Clinical Case Reports - Drug Safety 2018 (Canada)
- Medical Devices and Combination Product Regulations - Regulatory Affairs 2018 (USA)
- Medicinal Chemistry in Modern Drug Discovery - Drug Designing 2018 (Canada)
- Nanomedicine and Biomedical Applications - Pharma Congress 2018 (Poland)
- Nanotechnology in Clinical Trials and Research - Clinical Trials Congress 2018 (Singapore)
- Nanotechnology in Drug Discovery - Drug Designing 2018 (Canada)
- Natural products Drug Discovery - Drug Designing 2018 (Canada)
- Natural Supplements for Pain Management - Pain Medicine 2018 (USA)
- Novel Drug Delivery Systems - Pharma Congress 2018 (Poland)
- Novel Therapeutics in Drug Designing - Drug Designing 2018 (Canada)
- Office of generic drugs (OGD) - Generic Biosimilars 2018 (Germany)
- Orofacial Pain - Pain Medicine 2018 (USA)
- Outsourcing and Collaborative Research in Clinical Trials - Clinical Trials Congress 2018 (Singapore)
- Pain Management - Pain Medicine 2018 (USA)
- Pain Management Market - Pain Medicine 2018 (USA)
- Pain Management Nursing - Pain Medicine 2018 (USA)
- Pain Management Specialist - Pain Medicine 2018 (USA)
- Pain Medications - Pain Medicine 2018 (USA)
- Pain Medicine - Pain Medicine 2018 (USA)
- Patent access and intellectual property and FDA regulations - Generic Biosimilars 2018 (Germany)
- Patient Centric Clinical Trials - Clinical Trials Congress 2018 (Singapore)
- Penalties for Regulatory Non-compliance - Regulatory Affairs 2018 (USA)
- Pharma Market Research - Pharma Research 2018 (USA)
- Pharma pricing and market access - Generic Biosimilars 2018 (Germany)
- Pharmaceutical Analysis - Pharma Congress 2018 (Poland)
- Pharmaceutical and Biomedical Analysis - Drug Designing 2018 (Canada)
- Pharmaceutical Auditing for OTC Drugs - GMP and Pharma Audit 2018 (USA)
- Pharmaceutical Biotechnology - Pharma Congress 2018 (Poland)
- Pharmaceutical Biotechnology and Clinical Drug Evaluation - Drug Designing 2018 (Canada)
- Pharmaceutical Chemistry - Pharma Congress 2018 (Poland)
- Pharmaceutical Formulation - Pharma Congress 2018 (Poland)
- Pharmaceutical Formulation - Drug Designing 2018 (Canada)
- Pharmaceutical Manufacturing - Pharma Congress 2018 (Poland)
- Pharmaceutical Manufacturing,Scale Up and Tech transfer - Pharma Research 2018 (USA)
- Pharmaceutical Microbiology - Pharma Congress 2018 (Poland)
- Pharmaceutical Nanotechnology - Pharma Congress 2018 (Poland)
- Pharmaceutical Packaging - Pharma Congress 2018 (Poland)
- Pharmaceutical Packaging and Logistics - Pharma Research 2018 (USA)
- Pharmaceutical Process Validation - Pharma Congress 2018 (Poland)
- Pharmaceutical Regulatory Affairs And IPR - Euro Biopharma 2018 (Netherlands)
- Pharmaceutical Research and Development - Drug Designing 2018 (Canada)
- Pharmacoeconomics - Pharma Research 2018 (USA)
- Pharmacoepidemiology - Clinical Trials Congress 2018 (Singapore)
- Pharmacogenetics and Genomics - Pharma Congress 2018 (Poland)
- Pharmacogenomics - Clinical Trials Congress 2018 (Singapore)
- Pharmacognosy and Phytochemistry - Pharma Congress 2018 (Poland)
- Pharmacological Sciences - Pharma Congress 2018 (Poland)
- Pharmacology and drug developement - Generic Biosimilars 2018 (Germany)
- Pharmacovigilance - Euro Biopharma 2018 (Netherlands)
- Pharmacovigilance and Drug Safety - Pharma Congress 2018 (Poland)
- Pharmacovigilance and Drug Safety - Clinical Trials Congress 2018 (Singapore)
- Pharmacovigilance and safety of biosimilars - Generic Biosimilars 2018 (Germany)
- Pharmacovigilance of Biosimilars - Asian Biosimilars 2018 (Japan)
- Pharmacy Education and Practice - Pharma Congress 2018 (Poland)
- Physical Medicine and Rehabilitation - Pain Medicine 2018 (USA)
- Post Marketing Surveillance - Clinical Trials Congress 2018 (Singapore)
- Pre-Clinical and Clinical Trials - Drug Safety 2018 (Canada)
- Protein biotherapeutics and biosimilars - Generic Biosimilars 2018 (Germany)
- QC & QA: Quality control and Quality assurance - Pharma Research 2018 (USA)
- Quality Assurance - GMP and Pharma Audit 2018 (USA)
- Quality Assurance Audits in Pharma Industries - GMP and Pharma Audit 2018 (USA)
- Quality Assurance, Quality Control and Audit - GMP and Pharma Audit 2018 (USA)
- Quality by design(QbD) approach - Pharma Research 2018 (USA)
- Quality Control - GMP and Pharma Audit 2018 (USA)
- Quality control and R&D - Generic Biosimilars 2018 (Germany)
- Quality Management System in Testing Laboratories - GMP and Pharma Audit 2018 (USA)
- Regulatory Affairs - Regulatory Affairs 2018 (USA)
- Regulatory Affairs and Intellectual Property Rights - Pharma Congress 2018 (Poland)
- Regulatory Affairs in Pharmacovigilance - Regulatory Affairs 2018 (USA)
- Regulatory Approach for Biosimilars - Asian Biosimilars 2018 (Japan)
- Regulatory Authority Compliance - Pharma Research 2018 (USA)
- Regulatory Challenges for Medical Devices - Regulatory Affairs 2018 (USA)
- Regulatory Communications and Submissions - Regulatory Affairs 2018 (USA)
- Regulatory Requirements for Pharmaceuticals - Regulatory Affairs 2018 (USA)
- Regulatory Strategies and developments - Regulatory Affairs 2018 (USA)
- Risk assessment and management in clinical trials (QRM) - Clinical Trials Congress 2018 (Singapore)
- Role of c in cGMP - Regulatory Affairs 2018 (USA)
- Softwares in GMP and GCP - GMP and Pharma Audit 2018 (USA)
- Softwares in GMP and GCP - Regulatory Affairs 2018 (USA)
- Storage, Distribution, Transportation - GMP and Pharma Audit 2018 (USA)
- The Role of c in cGMP - GMP and Pharma Audit 2018 (USA)
- Therapeutic Biological Products - Euro Biopharma 2018 (Netherlands)
- Validation - GMP and Pharma Audit 2018 (USA)